Medical research should be accessible to every patient โ not just those with a science degree, a fast internet connection, or English as a first language. HealthBridge was built to close that gap.
Imagine you've been diagnosed with type 2 diabetes that isn't responding well to your current medication. Your doctor mentions that there might be trials for a new treatment class. You go home and try to look it up. You land on ClinicalTrials.gov and find 3,847 results for "type 2 diabetes." You open one. The eligibility criteria read: "HbA1c โฅ 7.0% and โค 10.5% at screening; eGFR โฅ 45 mL/min/1.73mยฒ per CKD-EPI; no prior use of SGLT2 inhibitors or GLP-1 receptor agonists within 3 months of randomization."
You close the tab.
This is the experience of millions of patients every day. HealthBridge was built to make it different.
HealthBridge connects to ClinicalTrials.gov's public API to search 490,000+ registered trials. You search by your condition in plain language ("I have diabetes" works; you don't need to know ICD codes), and filter by country. Results that are actively recruiting near you surface first.
Results are cached locally after your first search. If you lose internet connection โ on a bus, in a rural area, at a clinic with poor WiFi โ your saved trials and search results are still fully accessible.
For each trial, HealthBridge generates a plain-language summary that answers five questions:
HealthBridge uses Google's ML Kit Translation library, which runs entirely on your device. Translation models (about 15MB per language) download once on first use โ after that, translation works without any internet connection, indefinitely.
Supported languages: English, Spanish, Hindi, Swahili, French, Portuguese, Indonesian, Arabic, Bengali, Chinese (Simplified).
The offline-first approach isn't a technical choice โ it's a deliberate decision to serve patients in places where internet is unreliable or expensive. A patient in rural Kenya or Bihar can use HealthBridge on a basic Android phone with no data connection after the initial setup.
If you're considering a trial, HealthBridge can help you understand the consent document before you sign it. Point your camera at a printed consent form, and the app uses on-device OCR to extract the text, then translates it into your language in plain language โ all on your device, no data uploaded anywhere.
"I have type 2 diabetes but I also have kidney disease โ am I likely to qualify?" HealthBridge matches your question against the trial's inclusion and exclusion criteria using keyword matching and shows you the relevant excerpt. It can't give you a definitive answer โ that requires a physician โ but it can tell you whether kidney disease appears as an exclusion criterion in that specific trial before you spend an hour on the phone with a research coordinator.
Your health information is profoundly personal. HealthBridge is designed so that nothing you enter โ your condition, your eligibility questions, your translations โ ever leaves your device.
HealthBridge is built primarily for three groups:
HealthBridge is free for patients โ no ads, no subscription, no IAP. The revenue model is B2B: pharmaceutical companies and research organizations pay for qualified patient referrals. The patient always benefits for free.
This isn't charity โ it's alignment. Pharma's biggest problem in running trials is finding eligible, willing participants. HealthBridge's patients are exactly that. When a patient finds a relevant trial through HealthBridge and expresses interest in connecting with the research team, that referral has commercial value. The patient gets access; the sponsor gets a qualified lead; HealthBridge earns the connection fee.
Patients aren't the product. Pharma is the customer. That's the difference.
Join the beta โ find clinical trials in your language, understand what you're being asked to sign, and connect with research teams on your terms. Free for patients, always.
Learn More โHealthBridge is for informational purposes only. It does not provide medical advice and is not a substitute for consultation with a qualified physician before enrolling in any clinical trial.